(NTR) Nutrien - Ratings and Ratios
Fertilizers, Seeds, Crop Protection, Nitrogen, Potash, Phosphate
NTR EPS (Earnings per Share)
NTR Revenue
Description: NTR Nutrien
Nutrien Ltd. is a leading provider of crop inputs and services, operating through four distinct segments: Nutrien Ag Solutions, Potash, Nitrogen, and Phosphate. The companys diversified product portfolio includes crop nutrients, crop protection products, seeds, and merchandise products, as well as various services such as product application, soil and leaf testing, and precision agriculture. Nutriens business model is designed to support farmers and agricultural businesses, providing them with the necessary inputs and expertise to optimize crop yields and productivity.
From a financial perspective, Nutriens market capitalization stands at approximately $29.3 billion USD, with a forward price-to-earnings ratio of 15.34, indicating a relatively stable valuation. The companys return on equity (ROE) is 2.14, suggesting that Nutrien is generating returns on shareholder equity, albeit at a relatively modest level. To further assess the companys financial health, key performance indicators (KPIs) such as debt-to-equity ratio, interest coverage ratio, and dividend yield can be examined. For instance, Nutriens debt-to-equity ratio is around 0.63, indicating a moderate level of leverage. The companys dividend yield is approximately 3.4%, providing a relatively attractive return for income-focused investors.
In terms of operational performance, Nutriens segments demonstrate varying degrees of profitability. The Potash segment, in particular, is a significant contributor to the companys revenue, driven by demand for granular and standard potash products. The Nitrogen and Phosphate segments also play important roles, providing a range of products including ammonia, urea, and solid fertilizer. To gauge the companys operational efficiency, KPIs such as gross margin ratio, operating margin ratio, and asset turnover ratio can be analyzed. For example, Nutriens gross margin ratio is around 30%, indicating a relatively stable level of profitability. By examining these KPIs, investors can gain a more comprehensive understanding of Nutriens financial and operational performance.
NTR Stock Overview
| Market Cap in USD | 27,997m |
| Sub-Industry | Fertilizers & Agricultural Chemicals |
| IPO / Inception | 2018-01-02 |
NTR Stock Ratings
| Growth Rating | 17.9% |
| Fundamental | 49.2% |
| Dividend Rating | 76.5% |
| Return 12m vs S&P 500 | 8.25% |
| Analyst Rating | 3.88 of 5 |
NTR Dividends
| Dividend Yield 12m | 5.03% |
| Yield on Cost 5y | 8.12% |
| Annual Growth 5y | 3.71% |
| Payout Consistency | 100.0% |
| Payout Ratio | 62.9% |
NTR Growth Ratios
| Growth Correlation 3m | -69.8% |
| Growth Correlation 12m | 86.9% |
| Growth Correlation 5y | -6.1% |
| CAGR 5y | -9.67% |
| CAGR/Max DD 3y | -0.21 |
| CAGR/Mean DD 3y | -0.29 |
| Sharpe Ratio 12m | 0.84 |
| Alpha | 10.36 |
| Beta | 0.991 |
| Volatility | 26.29% |
| Current Volume | 2447.7k |
| Average Volume 20d | 2447.7k |
| Stop Loss | 55.2 (-3.1%) |
| Signal | 0.16 |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (1.36b TTM) > 0 and > 6% of Revenue (6% = 1.56b TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA -1.83pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 14.79% (prev 11.55%; Δ 3.24pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 3.67b > Net Income 1.36b (YES >=105%, WARN >=100%) |
| Net Debt (12.25b) to EBITDA (5.00b) ratio: 2.45 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.33 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (487.6m) change vs 12m ago -1.48% (target <= -2.0% for YES) |
| Gross Margin 29.18% (prev 30.12%; Δ -0.94pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 48.88% (prev 50.90%; Δ -2.02pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.71 (EBITDA TTM 5.00b / Interest Expense TTM 707.5m) >= 6 (WARN >= 3) |
Altman Z'' 2.46
| (A) 0.07 = (Total Current Assets 15.62b - Total Current Liabilities 11.77b) / Total Assets 53.26b |
| (B) 0.22 = Retained Earnings (Balance) 11.72b / Total Assets 53.26b |
| (C) 0.05 = EBIT TTM 2.62b / Avg Total Assets 53.12b |
| (D) 0.89 = Book Value of Equity 25.03b / Total Liabilities 28.14b |
| Total Rating: 2.46 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 49.22
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield 4.36% = 2.18 |
| 3. FCF Margin 6.60% = 1.65 |
| 4. Debt/Equity 0.50 = 2.38 |
| 5. Debt/Ebitda 2.53 = -1.01 |
| 6. ROIC - WACC -2.55% = -3.19 |
| 7. RoE 5.54% = 0.46 |
| 8. Rev. Trend -17.86% = -0.89 |
| 9. Rev. CAGR 9.23% = 1.15 |
| 10. EPS Trend -51.83% = -1.30 |
| 11. EPS CAGR -5.68% = -0.71 |
What is the price of NTR shares?
Over the past week, the price has changed by +0.92%, over one month by +1.61%, over three months by -4.88% and over the past year by +28.87%.
Is Nutrien a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NTR is around 56.74 USD . This means that NTR is currently overvalued and has a potential downside of -0.37%.
Is NTR a buy, sell or hold?
- Strong Buy: 10
- Buy: 5
- Hold: 8
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the NTR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 66.6 | 16.9% |
| Analysts Target Price | 66.6 | 16.9% |
| ValueRay Target Price | 62.4 | 9.5% |
Last update: 2025-09-01 04:56
NTR Fundamental Data Overview
CCE Cash And Equivalents = 1.39b USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 20.7266
P/E Forward = 12.6422
P/S = 1.1189
P/B = 1.1159
P/EG = 0.7229
Beta = 1.202
Revenue TTM = 25.96b USD
EBIT TTM = 2.62b USD
EBITDA TTM = 5.00b USD
Long Term Debt = 9.87b USD (from longTermDebt, last quarter)
Short Term Debt = 2.78b USD (from shortTermDebt, last quarter)
Debt = 12.65b USD (Calculated: Short Term 2.78b + Long Term 9.87b)
Net Debt = 12.25b USD (from netDebt column, last quarter)
Enterprise Value = 39.26b USD (28.00b + Debt 12.65b - CCE 1.39b)
Interest Coverage Ratio = 3.71 (Ebit TTM 2.62b / Interest Expense TTM 707.5m)
FCF Yield = 4.36% (FCF TTM 1.71b / Enterprise Value 39.26b)
FCF Margin = 6.60% (FCF TTM 1.71b / Revenue TTM 25.96b)
Net Margin = 5.25% (Net Income TTM 1.36b / Revenue TTM 25.96b)
Gross Margin = 29.18% ((Revenue TTM 25.96b - Cost of Revenue TTM 18.39b) / Revenue TTM)
Tobins Q-Ratio = 1.57 (Enterprise Value 39.26b / Book Value Of Equity 25.03b)
Interest Expense / Debt = 1.23% (Interest Expense 155.0m / Debt 12.65b)
Taxrate = 38.38% (436.0m / 1.14b)
NOPAT = 1.62b (EBIT 2.62b * (1 - 38.38%))
Current Ratio = 1.33 (Total Current Assets 15.62b / Total Current Liabilities 11.77b)
Debt / Equity = 0.50 (Debt 12.65b / last Quarter total Stockholder Equity 25.09b)
Debt / EBITDA = 2.53 (Net Debt 12.25b / EBITDA 5.00b)
Debt / FCF = 7.38 (Debt 12.65b / FCF TTM 1.71b)
Total Stockholder Equity = 24.62b (last 4 quarters mean)
RoA = 2.56% (Net Income 1.36b, Total Assets 53.26b )
RoE = 5.54% (Net Income TTM 1.36b / Total Stockholder Equity 24.62b)
RoCE = 7.61% (Ebit 2.62b / (Equity 24.62b + L.T.Debt 9.87b))
RoIC = 4.34% (NOPAT 1.62b / Invested Capital 37.24b)
WACC = 6.90% (E(28.00b)/V(40.65b) * Re(9.67%)) + (D(12.65b)/V(40.65b) * Rd(1.23%) * (1-Tc(0.38)))
Shares Correlation 3-Years: -90.91 | Cagr: -0.86%
Discount Rate = 9.67% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 64.88% ; FCFE base≈2.10b ; Y1≈1.46b ; Y5≈744.3m
Fair Price DCF = 22.98 (DCF Value 11.17b / Shares Outstanding 485.9m; 5y FCF grow -35.86% → 3.0% )
Revenue Correlation: -17.86 | Revenue CAGR: 9.23%
Rev Growth-of-Growth: 18.47
EPS Correlation: -51.83 | EPS CAGR: -5.68%
EPS Growth-of-Growth: 93.16
Additional Sources for NTR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle